Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
1180 Interim safety and efficacy results of Victoria-01: a phase 1 study to evaluate the safety and preliminary efficacy of SOT201 in patients with advanced/metastatic solid tumors
13 affiliations
- 1Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 2Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 3Center for Oncologic Research (CORE), University of Antwerp, Antwerp, Belgium
- 4Hospital Universitario Vall d’Hebron, Vall d’Hebron Institute of oncology (VHIO), Barcelona, Spain
- 5Early Clinical Drug Development Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
- 64Masaryk Memorial Cancer Institute (MMCI), Brno, CZE, Brno, Czech Republic
- 76SOTIO Biotech AG, Basel, Switzerland, Basel, Switzerland
- 8Medical Oncology, Jules Bordet Institute, Anderlecht, Belgium
- 91 SOTIO Biotech a.s, Prague, Czech Republic
- 10SOTIO Biotech AG, Basel, Switzerland
- 11UZA - University Hospital Antwerp, Edegem, Belgium
- 12Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Brussels, Belgium
- 13The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Related
- Multicentre randomised controlled trial to evaluate the efficacy of DIALIVE 2.0, a liver dialysis device, for the treatment of acute-on-chronic liver failure: study protocol
- A multicenter randomized controlled study to evaluate the efficacy of an artificial intelligence–based electrocardiography for the detection of atrial fibrillation in patients with suspected symptoms (DEEP-AF)
- AGE-related efficacy and safety of darolutamide triplet therapy in metastatic hormone-sensitive prostate cancer: are we ready for routine clinical practice?
- 334 Phase 1 trial of GC101, an IL2free autologous tumor-infiltrating lymphocyte (TIL) therapy, in recurrent high-grade glioma: safety and preliminary efficacy
- Anchored Drill-Assisted Localization for Percutaneous Endoscopic Cervical Keyhole Surgery in the Treatment of Cervical Spondylotic Radiculopathy: A Technical Report and Preliminary Efficacy Evaluation
BibTeX
@article{obermannova20261180,
title = {{1180 Interim safety and efficacy results of Victoria-01: a phase 1 study to evaluate the safety and preliminary efficacy of SOT201 in patients with advanced/metastatic solid tumors}},
author = {Radka Obermannova and Aung Naing and Hans Prenen and Elena Garralda and Vladimir Galvao and Peter Grell and Joachim Kiemle-Kallee and Nuria Kotecki and Lenka Palova Jelinkova and Vivi Boura and Wil Stevens and Bernd Dekeyser and Rita Saude Conde and Paulino Tallon De Lara},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.1180},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.1180},
note = {CC BY},
}
RIS
TY - JOUR
TI - 1180 Interim safety and efficacy results of Victoria-01: a phase 1 study to evaluate the safety and preliminary efficacy of SOT201 in patients with advanced/metastatic solid tumors
AU - Radka Obermannova
AU - Aung Naing
AU - Hans Prenen
AU - Elena Garralda
AU - Vladimir Galvao
AU - Peter Grell
AU - Joachim Kiemle-Kallee
AU - Nuria Kotecki
AU - Lenka Palova Jelinkova
AU - Vivi Boura
AU - Wil Stevens
AU - Bernd Dekeyser
AU - Rita Saude Conde
AU - Paulino Tallon De Lara
PY - 2026
DA - 2026/11/08
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.1180
UR - https://doi.org/10.1136/jitc-2026-sitc2026.1180
SN - 2051-1426
ER -